350 related articles for article (PubMed ID: 19124726)
1. IL-12-dependent inducible expression of the CD94/NKG2A inhibitory receptor regulates CD94/NKG2C+ NK cell function.
Sáez-Borderías A; Romo N; Magri G; Gumá M; Angulo A; López-Botet M
J Immunol; 2009 Jan; 182(2):829-36. PubMed ID: 19124726
[TBL] [Abstract][Full Text] [Related]
2. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
Gumá M; Busch LK; Salazar-Fontana LI; Bellosillo B; Morte C; García P; López-Botet M
Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674
[TBL] [Abstract][Full Text] [Related]
3. Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells.
Kusumi M; Yamashita T; Fujii T; Nagamatsu T; Kozuma S; Taketani Y
J Reprod Immunol; 2006 Jun; 70(1-2):33-42. PubMed ID: 16488482
[TBL] [Abstract][Full Text] [Related]
4. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.
Gumá M; Budt M; Sáez A; Brckalo T; Hengel H; Angulo A; López-Botet M
Blood; 2006 May; 107(9):3624-31. PubMed ID: 16384928
[TBL] [Abstract][Full Text] [Related]
5. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues.
Wada H; Matsumoto N; Maenaka K; Suzuki K; Yamamoto K
Eur J Immunol; 2004 Jan; 34(1):81-90. PubMed ID: 14971033
[TBL] [Abstract][Full Text] [Related]
6. The effect of mifepristone on the peripheral blood natural killer cell's cytotoxicity and expression of CD94/NKG2A and NKG2D during the implantation phase.
Chen XY; Zhuang YL; Li L; Zhang WW; Huang LL
Fertil Steril; 2010 May; 93(8):2615-20. PubMed ID: 19880106
[TBL] [Abstract][Full Text] [Related]
7. CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Morel E; Escamochero S; Cabañas R; Díaz R; Fiandor A; Bellón T
J Allergy Clin Immunol; 2010 Mar; 125(3):703-10, 710.e1-710.e8. PubMed ID: 20132973
[TBL] [Abstract][Full Text] [Related]
8. Expression of p58.2 or CD94/NKG2A inhibitory receptors in an NK-like cell line, YTINDY, leads to HLA Class I-mediated inhibition of cytotoxicity in the p58.2- but not the CD94/NKG2A-expressing transfectant.
Lin Chua H; Brahmi Z
Cell Immunol; 2002 Sep; 219(1):57-70. PubMed ID: 12473268
[TBL] [Abstract][Full Text] [Related]
9. The Activating NKG2C Receptor Is Significantly Reduced in NK Cells after Allogeneic Stem Cell Transplantation in Patients with Severe Graft-versus-Host Disease.
Kordelas L; Steckel NK; Horn PA; Beelen DW; Rebmann V
Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801784
[TBL] [Abstract][Full Text] [Related]
10. Functional anti-CD94/NKG2A and anti-CD94/NKG2C autoantibodies in patients with systemic lupus erythematosus.
Hagberg N; Theorell J; Hjorton K; Spee P; Eloranta ML; Bryceson YT; Rönnblom L
Arthritis Rheumatol; 2015 Apr; 67(4):1000-11. PubMed ID: 25510434
[TBL] [Abstract][Full Text] [Related]
11. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
[TBL] [Abstract][Full Text] [Related]
12. Rat and mouse CD94 associate directly with the activating transmembrane adaptor proteins DAP12 and DAP10 and activate NK cell cytotoxicity.
Saether PC; Hoelsbrekken SE; Fossum S; Dissen E
J Immunol; 2011 Dec; 187(12):6365-73. PubMed ID: 22084441
[TBL] [Abstract][Full Text] [Related]
13. CD3+/CD19+-depleted grafts in HLA-matched allogeneic peripheral blood stem cell transplantation lead to early NK cell cytolytic responses and reduced inhibitory activity of NKG2A.
Eissens DN; Schaap NP; Preijers FW; Dolstra H; van Cranenbroek B; Schattenberg AV; Joosten I; van der Meer A
Leukemia; 2010 Mar; 24(3):583-91. PubMed ID: 20033055
[TBL] [Abstract][Full Text] [Related]
14. Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection.
Jinushi M; Takehara T; Tatsumi T; Kanto T; Miyagi T; Suzuki T; Kanazawa Y; Hiramatsu N; Hayashi N
J Immunol; 2004 Nov; 173(10):6072-81. PubMed ID: 15528343
[TBL] [Abstract][Full Text] [Related]
15. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
[TBL] [Abstract][Full Text] [Related]
16. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
[TBL] [Abstract][Full Text] [Related]
17. Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis.
Galandrini R; Porpora MG; Stoppacciaro A; Micucci F; Capuano C; Tassi I; Di Felice A; Benedetti-Panici P; Santoni A
Fertil Steril; 2008 May; 89(5 Suppl):1490-6. PubMed ID: 17706207
[TBL] [Abstract][Full Text] [Related]
18. NK cell CD94/NKG2A inhibitory receptors are internalized and recycle independently of inhibitory signaling processes.
Borrego F; Kabat J; Sanni TB; Coligan JE
J Immunol; 2002 Dec; 169(11):6102-11. PubMed ID: 12444112
[TBL] [Abstract][Full Text] [Related]
19. Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease.
Seo J; Park JS; Nam JH; Bang D; Sohn S; Lee ES; Park KS
Tissue Antigens; 2007 Oct; 70(4):307-13. PubMed ID: 17767552
[TBL] [Abstract][Full Text] [Related]
20. The inhibitory receptor CD94/NKG2A on CD8
Eugène J; Jouand N; Ducoin K; Dansette D; Oger R; Deleine C; Leveque E; Meurette G; Podevin J; Matysiak T; Bennouna J; Bezieau S; Volteau C; Thomas WEA; Chetritt J; Kerdraon O; Fourquier P; Thibaudeau E; Dumont F; Mosnier JF; Toquet C; Jarry A; Gervois N; Bossard C
Mod Pathol; 2020 Mar; 33(3):468-482. PubMed ID: 31409873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]